The Wyss Center supports projects that will transform neurotechnology research ideas into clinical solutions. The Center offers access to the latest technology development platforms, as well as the expertise of the WISE team, to accelerate neurotechnology to the marketplace and help people with nervous system disorders live independent lives.
Projects to restore movement after paralysis.
Projects to restore touch, hearing, speech and vision or to combat pain.
Projects to help memory, language and psychiatric disorders.
Smart electronics for a malfunctioning nervous system.
Projects to restore function of organs.
The ultimate goal is to not only control robotic prostheses but directly trigger movement in …
Implantable systems that are capable of behaving like the body, and neither degrade nor cause …
Robot-based rehabilitation could help promote brain plasticity after stroke
The Wyss Center identifies and fosters high risk, high reward technology-linked solutions to treat nervous system disorders, creates prototype devices suitable for humans and then supports initial human clinical trials finally leading to commercialization to allow widespread benefit.
As a founding principle, all Wyss Center projects adhere to the highest ethical standards
We offer funding, scientific, business and regulatory expertise and access to the latest research facilities for high-risk, high return research driven technology development projects.
We will consider funding highly innovative projects from anywhere in the world as long as they meet the project requirements and make use of the Center’s capabilities and resources.
Repairing the nervous system with technology
Neurotechnology describes devices that can interact with the activity of the central nervous system.
Translating neurotechnology from the laboratory into clinical and commercial products has the potential to revolutionize the treatment of neurological diseases and disorders including paralysis as a result of stroke or trauma, pain, epilepsy, neuromuscular disease, motor neurone disease, Alzheimer’s disease and Parkinson’s disease.
Creating effective neurotechnologies depends upon knowledge and skill from neuroscience, engineering and clinical medicine to recognise credible innovations, build and test prototypes then advance them to early stage human clinical trials. This process requires clinical input, regulatory and business expertise from the very early stages to ensure sound design, feasible implementation for human use and commercial viability.
The Wyss Center combines these interdisciplinary skills with platforms equipped with state of the art infrastructure to enable the research and development needed to create and test cutting edge neurotechnology.
We are here to facilitate the design, development and implementation of new technology that can radically improve the lives of people living with neurological disorders.John Donoghue
Wyss Center Director
If you have an innovative idea for disruptive neurotechnology that could enable a revolution in how neurological disease or nervous system disorders are treated, please visit our 'apply for support' page and start the conversation.Find out more